ストックスクリーナーアプリを入手
8.95
1.38%
-0.125
アフターアワーズ：
9.02
0.07
+0.78%
前日終値:
$9.075
開ける：
$8.92
24時間の取引高:
944.34K
Relative Volume:
5.61
時価総額：
$117.71M
収益：
$1.93M
当期純損益:
$-7.96M
株価収益率:
-0.00253
EPS:
-3530.8178
ネットキャッシュフロー:
$-36.78M
1週間 パフォーマンス:
+7.19%
1か月 パフォーマンス:
+82.65%
6か月 パフォーマンス:
+21.77%
1年 パフォーマンス:
-12.00%
1日の値動き範囲:
$8.5846
$9.00
1週間の範囲:
$8.29
$9.88
52週間の値動き範囲:
$3.39
$16.00
Avalo Therapeutics Inc Stock (AVTX) Company Profile
AVTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
8.95 | 119.36M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-02 | 再開されました | H.C. Wainwright | Buy |
| 2025-03-25 | 開始されました | Jefferies | Buy |
| 2025-03-25 | 開始されました | Stifel | Buy |
| 2025-02-28 | 開始されました | Piper Sandler | Overweight |
| 2025-02-21 | 開始されました | Wedbush | Outperform |
| 2024-12-19 | 開始されました | BTIG Research | Buy |
| 2024-10-24 | 開始されました | H.C. Wainwright | Neutral |
| 2024-04-16 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-09-24 | 開始されました | RBC Capital Mkts | Outperform |
すべてを表示
Avalo Therapeutics Inc (AVTX) 最新ニュース
Avalo Therapeutics Inc. stock outlook for YEARPortfolio Update Summary & AI Based Buy and Sell Signals - Newser
Is Avalo Therapeutics Inc. reversing from oversold territoryEarnings Summary Report & Growth Oriented Trade Recommendations - Newser
Chart based exit strategy for Avalo Therapeutics Inc.Quarterly Earnings Summary & AI Powered Buy and Sell Recommendations - Newser
Avalo Therapeutics Reports Q2 2025 Financial Results - MSN
Avalo Therapeutics Inc.’s Beta Climbs After Market VolatilityEarnings Trend Report & Weekly Market Pulse Updates - sundaytimes.kr
News impact scoring models applied to Avalo Therapeutics Inc.Market Volume Summary & AI Enhanced Trading Alerts - Newser
What institutions are buying Avalo Therapeutics Inc. stock nowJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - Newser
Quantitative breakdown of Avalo Therapeutics Inc. recent move2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser
Avalo Therapeutics: Oppenheimer Maintains Buy Rating with $35 Price Target - AInvest
Using RSI to spot recovery in Avalo Therapeutics Inc.Market Growth Summary & Daily Risk Controlled Trade Plans - Newser
Why Avalo Therapeutics Inc. stock attracts strong analyst attentionIntraday Signal Forecast for Fast Traders - Newser
Should you wait for a breakout in Avalo Therapeutics Inc.Free Conservative Entry for High Return Setup - Newser
Custom strategy builders for tracking Avalo Therapeutics Inc.Trade Plan With Low Risk High Return - Newser
How to track smart money flows in Avalo Therapeutics Inc.Free Smart Trend Trading with Weekly Signals - Newser
Avalo Therapeutics Inc. stock chart pattern explainedFree Capital Preserving Trade Plan Templates - Newser
Avalo Therapeutics (AVTX) up more than 100% since Jul 15 - AInvest
Avalo Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is Avalo Therapeutics Inc. forming a reversal patternFree Buy Signal Based on Chart Analysis - Newser
Can Avalo Therapeutics Inc. recover in the next quarterWatchlist Generator With Real-Time Entry - Newser
Will a bounce in Avalo Therapeutics Inc. offer an exitMarket Timing Strategy with Technical Filters - Newser
How to forecast Avalo Therapeutics Inc. trends using time seriesFree Intraday Trend Analysis for Fast Gains - Newser
Analysts Offer Insights on Healthcare Companies: Avalo Therapeutics (AVTX), Iovance Biotherapeutics (IOVA) and NextCure (NXTC) - The Globe and Mail
Risk vs reward if holding onto Avalo Therapeutics Inc.Buy Point Strategy with Profit Protection - Newser
Can swing trading help recover from Avalo Therapeutics Inc. lossesLong Term Stock Planner with Safety Checks - Newser
Pattern recognition hints at Avalo Therapeutics Inc. upsideFree AI Screening for Swing Trade Picks - Newser
Buy Signal for Avalo Therapeutics Inc. Stock Key Technical Indicators to WatchIntraday Signal Forecast for Fast Traders - Newser
Avalo Therapeutics: Promising Phase 2 Trial and Market Opportunities Drive Buy Rating - TipRanks
Does Avalo Therapeutics Inc. stock pay reliable dividendsPrice Forecast Based on AI Analysis - Newser
What momentum shifts mean for Avalo Therapeutics Inc.AI Volatility Forecast and Risk Monitor - Newser
Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire
Risk adjusted return profile for Avalo Therapeutics Inc. analyzedFree Real-Time Market Sentiment Tracking Tool - Newser
Avalo Therapeutics Inc (AVTX) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
1.56%
大文字化:
|
ボリューム (24 時間):